Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) shares fell 3.5% during trading on Friday . The stock traded as low as $2.50 and last traded at $2.61. 1,068 shares traded hands during trading, a decline of 56% from the average session volume of 2,414 shares. The stock had previously closed at $2.70.
Relief Therapeutics Stock Down 3.5 %
The company has a 50 day moving average of $2.84 and a 200 day moving average of $4.15.
Relief Therapeutics Company Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Further Reading
- Five stocks we like better than Relief Therapeutics
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Google Is Betting Big on Nuclear Reactors—Should You?
- What is the Nikkei 225 index?
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Want to Profit on the Downtrend? Downtrends, Explained.
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
